AVI BioPharma, Inc. (AVII) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Price: $0.66 --0%
Financial Fact:
Total other non operating income: -209K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total other non operating income: -209K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
AVI BioPharma, Inc. (NASDAQ: AVII) reported Q1 EPS of ($0.13), $0.06 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $11.05 million.
For earnings history and earnings-related data on AVI BioPharma, Inc. (AVII) click here.
For earnings history and earnings-related data on AVI BioPharma, Inc. (AVII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
